CXCR2 Inhibition to Combat Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 100卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [21] Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
    Litman-Zawadzka, Ala
    Lukaszewicz-Zajac, Marta
    Gryko, Mariusz
    Kulczynska-Przybik, Agnieszka
    Kedra, Boguslaw
    Mroczko, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 12
  • [22] Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
    Zhengjie Dai
    Xuan Lin
    Xu Wang
    Xuan Zou
    Yu Yan
    Ruijie Wang
    Yusheng Chen
    Yesiboli Tasiheng
    Mingjian Ma
    Xu Wang
    He Cheng
    Xianjun Yu
    Chen Liu
    Cancer Immunology, Immunotherapy, 73
  • [23] Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma
    Dai, Zhengjie
    Lin, Xuan
    Wang, Xu
    Zou, Xuan
    Yan, Yu
    Wang, Ruijie
    Chen, Yusheng
    Tasiheng, Yesiboli
    Ma, Mingjian
    Wang, Xu
    Cheng, He
    Yu, Xianjun
    Liu, Chen
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (04)
  • [24] CXCR2 INHIBITION IMPROVES ISLET TRANSPLANTATION OUTCOME
    Citro, Antonio
    Melzi, Raffaella
    Cantarelli, Elisa
    Dugnani, Erica
    Daffonchio, Luisa
    Allegretti, Marcello
    Piemonti, Lorenzo
    TRANSPLANT INTERNATIONAL, 2011, 24 : 15 - 15
  • [25] Inhibition Of CXCR2 As a Therapeutic Strategy In AML and MDS
    Schinke, Carolina
    Giricz, Orsolya
    Gordon, Shanisha A. K.
    Barreyro, Laura
    Bhagat, Tushar D.
    Pellagatti, Andrea
    Boultwood, Jacqueline
    Yu, Yiting
    Steidl, Ulrich
    Verma, Amit
    BLOOD, 2013, 122 (21)
  • [26] CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer
    Donahue, Timothy R.
    Hines, O. Joe
    WORLD JOURNAL OF SURGERY, 2009, 33 (04) : 710 - 715
  • [27] CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer
    Timothy R. Donahue
    O. Joe Hines
    World Journal of Surgery, 2009, 33 : 710 - 715
  • [28] CXCR2 inhibition enables NASH-HCC immunotherapy
    Leslie, Jack
    Mackey, John B. G.
    Jamieson, Thomas
    Ramon-Gil, Erik
    Drake, Thomas M.
    Fercoq, Frederic
    Clark, William
    Gilroy, Kathryn
    Hedley, Ann
    Nixon, Colin
    Luli, Saimir
    Laszczewska, Maja
    Pinyol, Roser
    Esteban-Fabro, Roger
    Willoughby, Catherine E.
    Haber, Philipp K.
    Andreu-Oller, Carmen
    Rahbari, Mohammad
    Fan, Chaofan
    Pfister, Dominik
    Raman, Shreya
    Wilson, Niall
    Muller, Miryam
    Collins, Amy
    Geh, Daniel
    Fuller, Andrew
    McDonald, David
    Hulme, Gillian
    Filby, Andrew
    Cortes-Lavaud, Xabier
    Mohamed, Noha-Ehssan
    Ford, Catriona A.
    Iraolagoitia, Ximena L. Raffo
    McFarlane, Amanda J.
    McCain, Misti, V
    Ridgway, Rachel A.
    Roberts, Edward W.
    Barry, Simon T.
    Graham, Gerard J.
    Heikenwalder, Mathias
    Reeves, Helen L.
    Llovet, Josep M.
    Carlin, Leo M.
    Bird, Thomas G.
    Sansom, Owen J.
    Mann, Derek A.
    GUT, 2022, 71 (10) : 2093 - 2106
  • [29] Blockade of CXCR2 mediated granulocytic MDSC recruitment synergizes with CCR2 inhibition of inflammatory monocytes and restores anti-tumor immunity in pancreatic adenocarcinoma
    Nywening, Timothy M.
    Belt, Brian A.
    Panni, Roheena Z.
    Cullinan, Darren
    Sanford, Dominic E.
    Fields, Ryan C.
    Hawkins, William G.
    DeNardo, David G.
    Gillanders, William E.
    Goedegebuure, Peter
    Linehan, David C.
    CANCER RESEARCH, 2016, 76
  • [30] MAPK inhibition remodels antigen presentation in pancreatic ductal adenocarcinoma
    Creech, Amanda L.
    Le, Thuc M.
    Abt, Evan R.
    Capri, Joseph R.
    Donahue, Timothy R.
    Radu, Caius G.
    CANCER RESEARCH, 2022, 82 (12)
12345